Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.92 |
| ▸ | CA2 | P00918 | 4/20 | 0.92 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.92 |
| ▸ | CA9 | Q16790 | 3/20 | 0.92 |
| ▸ | CA3 | P07451 | 3/20 | 0.92 |
| ▸ | CA4 | P22748 | 3/20 | 0.92 |
| ▸ | CA1 | P00915 | 2/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.92 |
| ▸ | GLA | P06280 | 1/20 | 0.92 |
| ▸ | MMP3 | P08254 | 1/20 | 0.59 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.54 |
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | CA5A | P35218 | 3/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL786276 | 1.00 | — | — | |
| Phenol SCHEMBL9152178 | 1.00 | CA12 (0.92) | CA12CA2CA14CA9CA3 | |
| Phenol SCHEMBL361925 | 1.00 | CA12 (0.92) | CA12CA2CA14CA9CA3 | |
| Phenol SCHEMBL619965 | 1.00 | CA12 (0.92) | CA12CA2CA14CA9CA3 | |
| Phenol SCHEMBL27528742 | 1.00 | CA12 (0.92) | CA12CA2CA14CA9CA3 | |
| Phenol SCHEMBL11877136 | 1.00 | — | — | |
| Phenol SCHEMBL11448074 | 0.96 | — | — | |
| Phenol SCHEMBL10849088 | 0.96 | — | — | |
| Phenol SCHEMBL19328641 | 0.96 | CA12 (0.85) | CA12CA2CA14CA9CA3 | |
| Phenol SCHEMBL11092368 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125713-B1 | SULPHONIUM SALT PHOTOINITIATORS | BASF SE (DE) | 2012-04-18 | — | — | EP | disclosed |
| US-8012672-B2 | Sulphonium salt photoinitiators | BASF SE (DE) | 2011-09-06 | — | — | US | disclosed |
| US-20100087563-A1 | SULPHONIUM SALT PHOTOINITIATORS | BASF SE (DE) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087563-A1 | SULPHONIUM SALT PHOTOINITIATORS | SULT1A1, NCOR1, ARSA | CA12 2908/4885CA2 656/4885CA14 2667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.